Simethicone 125 MG Chewable Tablet [Gas-X] — RxCUI 210295
RxNorm drug concept · Semantic branded drug
RxCUI 210295
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
8 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI210295
Official nameSimethicone 125 MG Chewable Tablet [Gas-X]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asGas-X 125 MG Chewable Tablet; Gas-X Extra Strength 125 MG Chewable Tablet
FDA products mapped2
Package NDCs mapped8
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Simethicone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It relieves the discomfort of gas. For adults, that means pressure, bloating and fullness. Infant drops are for baby gas, often caused by swallowed air or certain formulas or foods...
- Shake the bottle well. Use only the syringe or dropper that came with it. Dispense it slowly toward the inner cheek. You can also mix it with 1 oz. of cool water, formula or anothe...
- Doses can be repeated as needed after meals and at bedtime. Do not go over 12 doses in a day. Follow your product’s label and your doctor’s advice.
- If you can, use your child’s weight. If not, use age. Check the chart on your product, and ask me or your doctor if you are unsure.
🕸️ Concept Web — How Simethicone 125 MG Chewable Tablet [Gas-X] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Simethicone 125 MG Chewable Tablet [Gas-X]
RxCUI 210295 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Simethicone
9796IN
-
Simethicone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Gas-X
217263BN
-
Gas-X
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Simethicone Chewable Tablet
373881SCDF -
Simethicone Chewable Product
1295710SCDG -
Simethicone Oral Product
1158751SCDG -
Simethicone Pill
1158752SCDG -
Simethicone Chewable Tablet [Gas-X]
369618SBDF -
Gas-X Chewable Product
1297095SBDG -
Gas-X Oral Product
1176036SBDG -
Gas-X Pill
1176037SBDG - +4 more in this family
-
Simethicone Chewable Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Simethicone 125 MG Chewable Tablet
314221SCD -
Simethicone 125 MG
317493SCDC -
Simethicone 125 MG [Gas-X]
2591359SBDC
-
Simethicone 125 MG Chewable Tablet
Showing up to 8 concepts per family — 13 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Simethicone 125 MG Chewable Tablet
SCD · 314221 -
Simethicone 125 MG
SCDC · 317493 -
Simethicone Chewable Tablet
SCDF · 373881 -
Simethicone Chewable Product
SCDG · 1295710 -
Simethicone Oral Product
SCDG · 1158751 -
Simethicone Pill
SCDG · 1158752
Brand-Name Concepts
-
Simethicone 125 MG [Gas-X]
SBDC · 2591359 -
Simethicone Chewable Tablet [Gas-X]
SBDF · 369618 -
Gas-X Chewable Product
SBDG · 1297095 -
Gas-X Oral Product
SBDG · 1176036 -
Gas-X Pill
SBDG · 1176037 -
Gas-X
BN · 217263
📦 FDA Products & Package NDCs
2 products · 8 package NDCs
8 package NDCs map to RxCUI 210295 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00067-0117-01 | 6 BLISTER PACK in 1 CARTON (0067-0117-01) / 12 TABLET, CHEW... | Gas-X Extra Strength | Haleon US Holdings LLC | 2012-01-01 |
| 00067-0117-18 | 2 BLISTER PACK in 1 CARTON (0067-0117-18) / 9 TABLET, CHEWA... | Gas-X Extra Strength | Haleon US Holdings LLC | 2012-01-01 |
| 00067-0117-27 | 3 BLISTER PACK in 1 CARTON (0067-0117-27) / 9 TABLET, CHEWA... | Gas-X Extra Strength | Haleon US Holdings LLC | 2012-01-01 |
| 00067-0117-48 | 4 BLISTER PACK in 1 CARTON (0067-0117-48) / 12 TABLET, CHEW... | Gas-X Extra Strength | Haleon US Holdings LLC | 2012-01-01 |
| 00067-0117-49 | 5 BLISTER PACK in 1 CARTON (0067-0117-49) / 12 TABLET, CHEW... | Gas-X Extra Strength | Haleon US Holdings LLC | 2012-01-01 |
| 00067-0129-18 | 2 BLISTER PACK in 1 CARTON (0067-0129-18) / 9 TABLET, CHEWA... | Gas-X Extra Strength | Haleon US Holdings LLC | 2012-12-01 |
| 00067-0129-27 | 3 BLISTER PACK in 1 CARTON (0067-0129-27) / 9 TABLET, CHEWA... | Gas-X Extra Strength | Haleon US Holdings LLC | 2012-12-01 |
| 00067-0129-48 | 4 BLISTER PACK in 1 CARTON (0067-0129-48) / 12 TABLET, CHEW... | Gas-X Extra Strength | Haleon US Holdings LLC | 2012-12-01 |
Observed labelers:
Haleon US Holdings LLC (8)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.